Highlights and Quick Summary
- EBIT for the quarter ending February 28, 2022 was $-7.04 Million (a -35.57% decrease compared to previous quarter)
- Year-over-year quarterly EBIT decreased by -27.77%
- Annual EBIT for 2021 was $-179 Million (a -34.79% decrease from previous year)
- Annual EBIT for 2020 was $-274 Million (a 163.52% increase from previous year)
- Annual EBIT for 2019 was $-104 Million (a 338.77% increase from previous year)
- Twelve month EBIT ending February 28, 2022 was $-46 Million (a -25.72% decrease compared to previous quarter)
- Twelve month trailing EBIT decreased by -47.97% year-over-year
Trailing EBIT for the last four month:
28 Feb '22 | 30 Nov '21 | 31 Aug '21 | 31 May '21 |
---|---|---|---|
$-46 Million | $-61.9 Million | $-72.4 Million | $-88.4 Million |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBIT of Organigram Holdings Inc.
Most recent EBITof OGI including historical data for past 10 years.Interactive Chart of EBIT of Organigram Holdings Inc.
Organigram Holdings Inc. EBIT for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | $-7.04 | – | – | – | – |
2021 | $-10.92 | $-18.28 | $-9.75 | $-22.97 | $-178.91 |
2020 | $-21.43 | $-34.24 | $-71.07 | $-3.06 | $-274.37 |
2019 | $0.12 | $-21.46 | $-8.42 | $-1.33 | $-104.12 |
2018 | – | – | $35.35 | $2.52 | $-23.73 |
2016 | – | – | – | – | $1.47 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic